Skip to content

2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid

C19H38N4O6 — CID 154907400

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid
SMILESCCN1CCN(CC(=O)NCC2CCCN(CCOC)C2)CC1.O=CO.O=CO
InChIInChI=1S/C17H34N4O2.2CH2O2/c1-3-19-7-9-21(10-8-19)15-17(22)18-13-16-5-4-6-20(14-16)11-12-23-2;2*2-1-3/h16H,3-15H2,1-2H3,(H,18,22);2*1H,(H,2,3)
InChIKeyAPDHYAZXHLQOLO-UHFFFAOYSA-N
MW418.54 g/mol
LogP-0.50
Rot. Bonds8

About 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid

2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid (PubChem CID 154907400) has the molecular formula C19H38N4O6 and a molecular weight of 418.54 g/mol. Its IUPAC name is 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid.

Molecular Properties

Compound Name2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid
PubChem CID154907400
Molecular FormulaC19H38N4O6
Molecular Weight418.54 g/mol
Exact Mass418.28
IUPAC Name2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid
SMILESCCN1CCN(CC(=O)NCC2CCCN(CCOC)C2)CC1.O=CO.O=CO
InChIInChI=1S/C17H34N4O2.2CH2O2/c1-3-19-7-9-21(10-8-19)15-17(22)18-13-16-5-4-6-20(14-16)11-12-23-2;2*2-1-3/h16H,3-15H2,1-2H3,(H,18,22);2*1H,(H,2,3)
InChIKeyAPDHYAZXHLQOLO-UHFFFAOYSA-N
XLogP-0.50
TPSA122.65 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500418.54
LogP ≤ 5-0.50
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid?
The IUPAC name of 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid (CID 154907400) is 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid.
What is the SMILES notation for 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid?
The canonical SMILES for 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid is CCN1CCN(CC(=O)NCC2CCCN(CCOC)C2)CC1.O=CO.O=CO.
What is the InChIKey of 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid?
The InChIKey is APDHYAZXHLQOLO-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H34N4O2.2CH2O2/c1-3-19-7-9-21(10-8-19)15-17(22)18-13-16-5-4-6-20(14-16)11-12-23-2;2*2-1-3/h16H,3-15H2,1-2H3,(H,18,22);2*1H,(H,2,3).
What are the key properties of 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid?
2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid has a molecular weight of 418.54 g/mol, XLogP of -0.50, 8 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-ethylpiperazin-1-yl)-N-[[1-(2-methoxyethyl)piperidin-3-yl]methyl]acetamide;formic acid is sourced from PubChem (CID 154907400), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.